| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CCR.2011.01.001 |
| P698 | PubMed publication ID | 21316602 |
| P50 | author | Shi-Mei Zhuang | Q63647398 |
| P2093 | author name string | Qinghua Zhang | |
| Li Lin | |||
| Lunxiu Qin | |||
| Xuetao Cao | |||
| Qian Zhang | |||
| Yun Yang | |||
| Jin Hou | |||
| Wei Tian | |||
| Anmin Liang | |||
| Xiaobing Wu | |||
| Weiping Zhou | |||
| Zhengxin Wang | |||
| Yuanyuan Zheng | |||
| Limin Zheng | |||
| Chunmei Wang | |||
| Qiongzhu Dong | |||
| Guoshan Ding | |||
| Wenzhao Tao | |||
| P2860 | cites work | Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression | Q37269259 |
| P433 | issue | 2 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 232-243 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma | |
| P478 | volume | 19 |
| Q92747215 | A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression |
| Q35153904 | A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population |
| Q34185805 | A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma |
| Q37453234 | A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese |
| Q48604832 | A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance |
| Q34216030 | A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus |
| Q36968033 | ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells |
| Q37252581 | Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis |
| Q35171752 | An integrative meta-analysis of microRNAs in hepatocellular carcinoma. |
| Q38772085 | Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells |
| Q27307206 | Anti-tumor activity of a miR-199-dependent oncolytic adenovirus |
| Q36746133 | Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma |
| Q55182677 | Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease. |
| Q37694792 | Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma. |
| Q58699460 | Association of plasma microRNA expression with age, genetic background and functional traits in dairy cattle |
| Q34359354 | Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. |
| Q61810563 | Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity |
| Q38115692 | Biogenesis, evolution and functional targets of microRNA-125a. |
| Q33676412 | Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation |
| Q36413308 | CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration |
| Q39016536 | CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas |
| Q45324234 | Cellular microRNA networks regulate host dependency of hepatitis C virus infection. |
| Q30725051 | Characteristic Analysis from Excessive to Deficient Syndromes in Hepatocarcinoma Underlying miRNA Array Data |
| Q38682730 | Characterization of mouse serum exosomal small RNA content: The origins and their roles in modulating inflammatory response |
| Q34896601 | Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy |
| Q88097347 | Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression |
| Q64086115 | Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression |
| Q50315404 | Circulating liver-specific microRNAs in cynomolgus monkeys |
| Q92758675 | Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis |
| Q87473578 | Clinical significance of microRNA expressions in diagnosing uterine cancer and predicting lymph node metastasis |
| Q35101445 | Co-modulated behavior and effects of differentially expressed miRNA in colorectal cancer |
| Q34529730 | Comprehensive analysis of microRNAs in breast cancer |
| Q34947801 | Comprehensive characterization of 10,571 mouse large intergenic noncoding RNAs from whole transcriptome sequencing |
| Q39109383 | Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer |
| Q38366584 | Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis |
| Q35197356 | DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. |
| Q28079848 | Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? |
| Q33838155 | Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma |
| Q42832638 | Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid |
| Q38245905 | Delivery and targeting of miRNAs for treating liver fibrosis |
| Q41053182 | Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies |
| Q64099533 | Development of miRNA-based therapeutic approaches for cancer patients |
| Q38334014 | Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma. |
| Q26999043 | Diagnostic and therapeutic management of hepatocellular carcinoma |
| Q47366717 | Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action |
| Q33649970 | Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers |
| Q36512091 | Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways |
| Q30562511 | Discovery of hundreds of mirtrons in mouse and human small RNA data |
| Q64231304 | Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway |
| Q92447657 | Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma |
| Q47393235 | Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation. |
| Q38980944 | Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. |
| Q41562520 | Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer |
| Q31052484 | Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix |
| Q35843220 | Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis |
| Q36069392 | Dysregulated miR-645 affects the proliferation and invasion of head and neck cancer cell |
| Q98771219 | Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets |
| Q34168267 | ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer |
| Q37082823 | Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer |
| Q64240700 | Epigenetics of hepatocellular carcinoma |
| Q38136179 | Epigenetics of hepatocellular carcinoma: role of microRNA |
| Q28025433 | Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes |
| Q34307845 | Evolution of the human-specific microRNA miR-941. |
| Q47239489 | Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. |
| Q34028475 | Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma |
| Q34270516 | Extent, causes, and consequences of small RNA expression variation in human adipose tissue |
| Q46588142 | Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma |
| Q42967810 | Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma |
| Q36626898 | Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. |
| Q42977945 | Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p |
| Q24610158 | Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a |
| Q28073703 | Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease |
| Q28485293 | Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines |
| Q42229509 | Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection |
| Q39181475 | Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma |
| Q92096902 | Gestational diabetes and maternal obesity are associated with sex-specific changes in miRNA and target gene expression in the fetus |
| Q45323932 | Global micro RNA expression profiling in the liver biopsies of Hepatitis B Virus infected patients suggests specific miRNA signatures for viral persistence and hepatocellular injury |
| Q26774494 | Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer |
| Q90147486 | HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells |
| Q40291586 | Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma. |
| Q24315118 | Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma |
| Q59353315 | Hepatitis B Virus Induces Autophagy to Promote its Replication by the Axis of miR-192-3p-XIAP via NF-κB Signaling |
| Q36947870 | Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes |
| Q37680071 | Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma |
| Q27024630 | Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases |
| Q28818406 | Hepatitis B virus molecular biology and pathogenesis |
| Q55380360 | Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA. |
| Q59355718 | Hepatitis B virus upregulates host microRNAs that target apoptosis-regulatory genes in an in vitro cell model |
| Q37642739 | High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition |
| Q34126628 | High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays |
| Q45040941 | High-throughput miRNA sequencing and identification of biomarkers for forensically relevant biological fluids |
| Q34405141 | Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene |
| Q34055926 | Identification and characterization of a novel non-coding RNA involved in sperm maturation |
| Q36368796 | Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells |
| Q64937620 | Identification of microRNA-124 in regulation of Hepatocellular carcinoma through BIRC3 and the NF-κB pathway. |
| Q37316633 | Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma |
| Q21134574 | Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma |
| Q64914155 | Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database. |
| Q89375879 | Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies |
| Q40076710 | Impact of the Interaction between 3'-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes. |
| Q27005850 | Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy |
| Q42365294 | Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression |
| Q37406865 | Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN. |
| Q30660817 | Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis |
| Q91951381 | Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets |
| Q28080281 | Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention |
| Q31140554 | Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma |
| Q35936416 | Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells |
| Q37404724 | Intramyocardial Injection of siRNAs Can Efficiently Establish Myocardial Tissue-Specific Renalase Knockdown Mouse Model. |
| Q30776344 | Investigation of key microRNAs associated with hepatocellular carcinoma using small RNA-seq data |
| Q41602224 | Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. |
| Q28079138 | Involvement of inflammation and its related microRNAs in hepatocellular carcinoma |
| Q37225302 | Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility |
| Q35781503 | Ku80 cooperates with CBP to promote COX-2 expression and tumor growth |
| Q34207989 | Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 |
| Q35913384 | Liver cancer oncogenomics: opportunities and dilemmas for clinical applications |
| Q90480696 | Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression |
| Q37576329 | Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma |
| Q39329786 | Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy |
| Q45334856 | Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans |
| Q35692283 | Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation |
| Q41850183 | Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice |
| Q38983737 | MEK inhibitor effective against proliferation in breast cancer cell |
| Q42180490 | Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells |
| Q38821957 | MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling |
| Q49744015 | Melanocyte-specific gene 1 promotes melanoma progression by enhancing the expression of Bcl-2. |
| Q47701375 | MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis |
| Q36197033 | MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1. |
| Q34391551 | MiR-139-5p inhibits HGTD-P and regulates neuronal apoptosis induced by hypoxia-ischemia in neonatal rats |
| Q34338509 | MiR-199a regulates cell proliferation and survival by targeting FZD7. |
| Q54977131 | MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4. |
| Q55057043 | MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. |
| Q92392798 | MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway |
| Q49197441 | MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway |
| Q41812357 | MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1 |
| Q38913478 | MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. |
| Q38301327 | MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1. |
| Q41592983 | MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma |
| Q36623848 | MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc. |
| Q90115177 | MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth |
| Q35904190 | MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients |
| Q37535443 | MiRNA-199a-3p regulates C2C12 myoblast differentiation through IGF-1/AKT/mTOR signal pathway |
| Q33555052 | MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma |
| Q21560965 | Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis |
| Q57491234 | Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma |
| Q37031706 | Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma |
| Q34530125 | MicroRNA 3' end nucleotide modification patterns and arm selection preference in liver tissues |
| Q90266684 | MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis |
| Q35202304 | MicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature |
| Q97073636 | MicroRNA let-7b inhibits cell proliferation via upregulation of p21 in hepatocellular carcinoma |
| Q34584221 | MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large |
| Q37924177 | MicroRNA replacement therapy for cancer |
| Q59350529 | MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors |
| Q43560853 | MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma |
| Q41894824 | MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line |
| Q84598388 | MicroRNA-199a/b-3p: a new star in the liver microcosmos |
| Q38640499 | MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1. |
| Q88660923 | MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation |
| Q90284819 | MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma |
| Q34407669 | MicroRNA-223 coordinates cholesterol homeostasis |
| Q30009025 | MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy |
| Q85962927 | MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1 |
| Q38995250 | MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase |
| Q39426037 | MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers |
| Q28251819 | MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4) |
| Q39038019 | MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B. |
| Q37727846 | MicroRNA-466l inhibits antiviral innate immune response by targeting interferon-alpha |
| Q39414132 | MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma |
| Q58784244 | MicroRNA-744 promotes cell apoptosis via targeting B cell lymphoma-2 in gastric cancer cell line SGC-7901 |
| Q92591768 | MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2 |
| Q35378724 | MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. |
| Q60912969 | MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer |
| Q37330550 | MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. |
| Q26773254 | MicroRNA-mediated interactions between host and hepatitis C virus |
| Q58704496 | MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma |
| Q26773183 | MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations |
| Q34322197 | MicroRNAs and atherosclerosis. |
| Q38018170 | MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy |
| Q89287914 | MicroRNAs and liver disease |
| Q26765476 | MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma |
| Q26751392 | MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma |
| Q34284404 | MicroRNAs associated with HBV infection and HBV-related HCC. |
| Q35715931 | MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine |
| Q91726315 | MicroRNAs in Animal Models of HCC |
| Q36739805 | MicroRNAs in Liver Health and Disease |
| Q38209676 | MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target |
| Q55444653 | MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. |
| Q34675280 | MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. |
| Q33880442 | MicroRNAs in liver disease |
| Q51793583 | MicroRNAs in liver disease. |
| Q30439971 | MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma |
| Q26750448 | MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases |
| Q26827668 | MicroRNAs may solve the mystery of chronic hepatitis B virus infection |
| Q64249125 | MicroRNAs mediate liver transcriptome changes upon soy diet intervention in mice |
| Q45366262 | MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. |
| Q35752063 | MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas |
| Q38053397 | MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? |
| Q56527730 | Microarray analysis of microRNA expression in liver cancer tissues and normal control |
| Q33698542 | Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α |
| Q35082694 | Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas |
| Q58130121 | NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling |
| Q41990459 | New Insights into the Epigenetics of Hepatocellular Carcinoma. |
| Q36962430 | Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein |
| Q38541359 | Non-Coding RNAs in Primary Liver Cancer |
| Q37358612 | Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy |
| Q47215507 | Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications |
| Q35592207 | Noncoding RNA as therapeutic targets for hepatocellular carcinoma. |
| Q37578782 | Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis |
| Q90884159 | Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy |
| Q28391713 | Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth |
| Q41886234 | Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice. |
| Q89768116 | Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition |
| Q92068838 | Overview of microRNA-199a Regulation in Cancer |
| Q38198494 | P21 activated kinases: structure, regulation, and functions |
| Q41592706 | PAK4-6 in cancer and neuronal development |
| Q38831430 | PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells |
| Q37741239 | PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma |
| Q34422999 | Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer |
| Q37291611 | Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease |
| Q49679382 | Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma. |
| Q90465621 | Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data |
| Q54117850 | Potential tumor suppressing role of microRNA-545 in epithelial ovarian cancer. |
| Q34328342 | Profiling and identification of small rDNA-derived RNAs and their potential biological functions |
| Q92615766 | Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors |
| Q30629629 | Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data |
| Q48001115 | Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression |
| Q28392770 | Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer |
| Q36110358 | Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma |
| Q36796821 | Reduction of the ST6 β-galactosamide α-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2/cell adhesion molecule 1 and enhancement of ErbB2/ErbB3 signaling by microRNA-199a |
| Q38153384 | Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs |
| Q94205936 | Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of th |
| Q36709645 | Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells |
| Q34493653 | Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10 |
| Q36997713 | Regulation of viral oncogenesis by microRNAs |
| Q51048228 | Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma. |
| Q36945012 | Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma |
| Q34648156 | Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer |
| Q31103041 | Retracted: MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 |
| Q27014034 | Role of microRNAs in hepatocellular carcinoma: a clinical perspective |
| Q92180505 | SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways |
| Q34486409 | SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer |
| Q33626735 | Screening candidate microRNAs (miRNAs) in different lambskin hair follicles in Hu sheep |
| Q39411457 | Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. |
| Q64255606 | Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma |
| Q36411874 | Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection |
| Q41377011 | Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization |
| Q37713066 | Several microRNAs could predict survival in patients with hepatitis B-related liver cancer |
| Q64938563 | Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma. |
| Q55401749 | Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. |
| Q34457081 | Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C |
| Q38779105 | Structure, biochemistry, and biology of PAK kinases |
| Q57811391 | Synergistic and independent action of endogenous microRNAs 122a and 199a for post-transcriptional liver detargeting of gene vectors |
| Q28115468 | TBCK influences cell proliferation, cell size and mTOR signaling pathway |
| Q83600789 | TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p |
| Q45874034 | Targeted delivery of miR-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma |
| Q38585471 | Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma |
| Q39664369 | Targeting liver cancer: first steps toward a miRacle? |
| Q35215896 | The "Macro" World of microRNAs in Hepatocellular Carcinoma. |
| Q89110941 | The Nogo-B receptor promotes human hepatocellular carcinoma cell growth via the Akt signal pathway |
| Q53175931 | The Role of miRNAs in Virus-Mediated Oncogenesis. |
| Q47553075 | The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity |
| Q55689746 | The Role of microRNAs in Embryonic and Induced Pluripotency |
| Q89687502 | The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis |
| Q33724231 | The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis |
| Q90703773 | The clinical potential of circulating microRNAs in obesity |
| Q87418776 | The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer |
| Q92151502 | The contribution of miR-122 to the innate immunity by regulating toll-like receptor 4 in hepatoma cells |
| Q38968725 | The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels. |
| Q35793799 | The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. |
| Q59330317 | The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene |
| Q34571691 | The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis |
| Q33622318 | The miRNAome of the postpartum dairy cow liver in negative energy balance |
| Q27693213 | The microRNA miR-124 suppresses seizure activity and regulates CREB1 activity |
| Q38213933 | The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. |
| Q38164571 | The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. |
| Q27016620 | The role of p21-activated kinases in hepatocellular carcinoma metastasis |
| Q50276385 | Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects |
| Q26743361 | Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma |
| Q64238313 | Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer |
| Q37050654 | Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis |
| Q34263334 | Transcriptional profiling and dynamical regulation analysis identify potential kernel target genes of SCYL1-BP1 in HEK293T cells |
| Q33748950 | Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver |
| Q36593582 | Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression |
| Q36364602 | Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs |
| Q38008950 | Translational medicine in hepatocellular carcinoma |
| Q24608195 | Tumor markers for hepatocellular carcinoma (Review) |
| Q59355189 | Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy |
| Q31106715 | Unmasking Upstream Gene Expression Regulators with miRNA-corrected mRNA Data |
| Q36545975 | Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. |
| Q41615311 | Upregulation of miR-520b promotes ovarian cancer growth |
| Q35120104 | Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells |
| Q31073758 | Using Small RNA Deep Sequencing Data to Detect Human Viruses |
| Q35908666 | VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma |
| Q47782244 | Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease. |
| Q28590069 | Zinc finger protein ZBTB20 promotes Toll-like receptor-triggered innate immune responses by repressing IκBα gene transcription |
| Q87445094 | [Exploiting the therapeutic potential of microRNAs in human cancer] |
| Q38923535 | c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma |
| Q85198781 | c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma |
| Q112758193 | circTulp4 functions in Alzheimer's disease pathogenesis by regulating its parental gene, Tulp4 |
| Q37685458 | hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. |
| Q90468430 | lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression |
| Q39162380 | miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). |
| Q38955621 | miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma |
| Q90170080 | miR-143 promotes angiogenesis and osteoblast differentiation by targeting HDAC7 |
| Q54196607 | miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3. |
| Q26744201 | miR-181a induces sorafenib resistance of hepatocellular carinoma cells through downregulation of RASSF1 expression |
| Q33685465 | miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma |
| Q35739550 | miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients |
| Q54963896 | miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model. |
| Q38731881 | miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma |
| Q34704872 | miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL. |
| Q37636676 | miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. |
| Q36729569 | miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators |
| Q37448131 | miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB. |
| Q38804742 | miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis |
| Q39119238 | miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. |
| Q33731757 | miR-639 promotes the proliferation and invasion of breast cancer cell in vitro |
| Q37688892 | miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway |
| Q53693968 | miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1. |
| Q41856059 | miR199a-3p regulates P53 by targeting CABLES1 in mouse cardiac c-kit+ cells to promote proliferation and inhibit apoptosis through a negative feedback loop |
| Q38838281 | miRCat2: accurate prediction of plant and animal microRNAs from next-generation sequencing datasets |
| Q35633577 | miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades |
| Q34673760 | miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer |
| Q37652976 | miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma |
| Q91639304 | miRNome Reveals New Insights Into the Molecular Biology of Field Cancerization in Gastric Cancer |
| Q37394073 | miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. |
| Q33993061 | miRSeq: a user-friendly standalone toolkit for sequencing quality evaluation and miRNA profiling. |
| Q35964688 | miTALOS v2: Analyzing Tissue Specific microRNA Function |
| Q31141908 | microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection |
| Q37211707 | microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin |
| Q100962279 | microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4 |
| Q36890242 | microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. |
| Q40873221 | microRNAs and Hepatitis B. |
| Q28709088 | pseudoMap: an innovative and comprehensive resource for identification of siRNA-mediated mechanisms in human transcribed pseudogenes |
| Q38896403 | β2-AR signaling controls trastuzumab resistance-dependent pathway |
Search more.